Tanaka Junichi, Yan Yuling, Choi Jeongeun, Bai Jihong, Klenchin Vadim A, Rayment Ivan, Marriott Gerard
Department of Physiology, University of Wisconsin, 1300 University Avenue, Madison, WI 53706, USA.
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13851-6. doi: 10.1073/pnas.2233339100. Epub 2003 Nov 11.
This study characterizes the interactions between kabiramide C (KabC) and related macrolides and actin and establishes the mechanisms that underlie their inhibition of actin filament dynamics and cytotoxicity. The G-actin-KabC complex is formed through a two-step binding reaction and is extremely stable and long-lived. Competition-binding studies show that KabC binds to the same site on G-actin as Gelsolin domain 1 and CapG. KabC also binds to protomers within F-actin and results in the severing and capping of the (+) end; these studies suggest that free KabC and related macrolides act as biomimetics of Gelsolin. The G-actin-KabC complex binds to the (+) end of a growing filament, where it functions as a novel, unregulated, (+)-end capper and is largely responsible for the inhibition of motility and cytokinesis in approximately 10 -100 nM KabC-treated cells. KabC and related macrolides are useful probes to study the regulation of the actin filament (+) end and may lead to new therapies to treat diseases of the actin cytoskeleton.
本研究对卡比拉胺C(KabC)与相关大环内酯类化合物和肌动蛋白之间的相互作用进行了表征,并确定了其抑制肌动蛋白丝动力学和细胞毒性的潜在机制。G-肌动蛋白-KabC复合物通过两步结合反应形成,极其稳定且寿命长。竞争结合研究表明,KabC与G-肌动蛋白上与凝溶胶蛋白结构域1和CapG相同的位点结合。KabC还与F-肌动蛋白中的原聚体结合,导致(+)端的切断和封端;这些研究表明,游离的KabC和相关大环内酯类化合物起到了凝溶胶蛋白的模拟物作用。G-肌动蛋白-KabC复合物与正在生长的细丝的(+)端结合,在那里它作为一种新型的、不受调控的(+)端封端剂发挥作用,并且在很大程度上导致了在约10 - 100 nM KabC处理的细胞中运动性和胞质分裂的抑制。KabC和相关大环内酯类化合物是研究肌动蛋白丝(+)端调控的有用探针,并可能带来治疗肌动蛋白细胞骨架疾病的新疗法。